[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Oilfield Scale Inhibitor Market by Type (Phosphonates, Carboxylate/Acrylic, Sulfonates, and Others), and by Region (North America, Europe, Asia-Pacific, Middle East, Africa, and South America) - Global Forecast to 2020

February 2016 | 151 pages | ID: S8C2353FCB9EN
MarketsandMarkets

US$ 5,650.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global oilfield scale inhibitor market size is projected to reach USD 697.5 million by 2020

The global oilfield scale inhibitor market size is projected to reach USD 697.5 million by 2020, from USD 509.4 million in 2014, registering a CAGR of 5.40% between 2015 and 2020. The main reasons for the growth of this market are growing demand from the oil and gas industry, wide availability of scale inhibitors, and growing demand for biodegradable scale inhibitors due to strict environmental rules and regulations.

RoW: The largest market for oilfield scale inhibitor

RoW region, which includes the Middle-East, Africa, and South America, is the global leader in the consumption of scale inhibitors, and this dominance is expected to continue till 2020. RoW region has some of the biggest oil producing countries in the world. Huge proven oil reserves and rapid oil & gas exploration activities are driving the RoW market of oilfield scale inhibitor. The RoW market is also expected to witness the highest CAGR between 2015 and 2020.

Carboxylate/Acrylic: The largest type segment for oilfield scale inhibitor

Carboxylate/acrylic is the largest type segment for the oilfield scale inhibitor market. The environment-friendly nature of carboxylate/acrylic scale inhibitors makes it more preferable in comparison to the other types. However, the market for the sulfonates type is expected to grow at the highest CAGR during the forecast period. Barium sulphates is the common scales that formed during oil exploration activities. The sulfonates type of scale inhibitors is used to prevent sulphate scales, and are also used in the desalination process.

Breakdown of profile of primary participants:
  • By Company Type: Tier 1 - 35%, Tier 2 - 45% and Tier 3 - 20%
  • By Designation: C level - 35%, Director Level- 25%, Others- 40%
  • By Region: North America - 45%, APAC – 30%, Europe- 20%, RoW - 5%
As a part of qualitative analysis, the report provides a comprehensive review of major market drivers, restraints, opportunities, and challenges. It also discusses competitive strategies adopted by different market players, such as The Dow Chemical Company (U.S.), BASF SE (Germany), AkzoNobel Oilfield (The Netherlands), Kemira OYJ (Finland), Solvay S.A. (Belgium), Halliburton Company (U.S.), Schlumberger Limited (U.S.), Baker Hughes Incorporated (U.S.), Clariant AG (Switzerland), E. I. du Pont de Nemours and Company (U.S.), Evonik Industries AG (Germany), GE Power & Water Process Technologies (U.S.), Ashland Inc. (U.S.), Innospec Inc. (U.S.), and others.

Reasons to buy this report:

This report covers the following key aspects:
  • What will be the market size by 2020 and what will be the growth rate
  • What are the key market trends
  • What is driving this market
  • What are the challenges that impact market growth
  • Who are the key players in this market
  • Global report covers key regions, such as North America, Europe, Asia-Pacific, and RoW, with major countries in each regions
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED IN THE REPORT
1.4 CURRENCY
1.5 PACKAGING & SIZING
1.6 LIMITATIONS
1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
    2.1.2.3 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
  2.2.1 BOTTOM-UP APPROACH
  2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE OPPORTUNITIES IN SCALE INHIBITORS MARKET
4.2 SCALE INHIBITORS MARKET, BY TYPE (2015-2020)
4.3 SCALE INHIBITORS MARKET SHARE IN ASIA-PACIFIC, 2014
4.4 LEADING COUNTRIES AND REGION MARKET SHARE IN THE SCALE INHIBITORS MARKET, 2014
4.5 SCALE INHIBITORS MARKET SIZE, BY REGION AND BY TYPE, 2014
4.6 LIFECYCLE ANALYSIS, BY REGION

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
  5.2.1 BY TYPE
  5.2.2 BY REGION
5.3 MARKET DYNAMICS
  5.3.1 DRIVERS
    5.3.1.1 Rising demand from oil & gas industry
    5.3.1.2 Wide availability of scale inhibitors
    5.3.1.3 Growing demand of biodegradable scale inhibitors
  5.3.2 RESTRAINTS
    5.3.2.1 Environmental and handling effects of scale inhibitors
  5.3.3 OPPORTUNITIES
    5.3.3.1 Increase in offshore spending
    5.3.3.2 Potential new oilfield discovery
  5.3.4 CHALLENGES
    5.3.4.1 Current low oil prices
    5.3.4.2 Geopolitics & political unrest

6 INDUSTRY TRENDS

6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 PORTER’S FIVE FORCES ANALYSIS
  6.3.1 BARGAINING POWER OF SUPPLIERS
  6.3.2 THREAT OF NEW ENTRANTS
  6.3.3 THREAT OF SUBSTITUTES
  6.3.4 BARGAINING POWER OF BUYERS
  6.3.5 INTENSITY OF RIVALRY

7 SCALE INHIBITORS MARKET, BY TYPE

7.1 INTRODUCTION
7.2 MARKET SIZE & PROJECTION
7.3 PHOSPHONATES
7.4 CARBOXYLATE/ACRYLIC
7.5 SULFONATES
7.6 OTHERS

8 REGIONAL ANALYSIS

8.1 INTRODUCTION
8.2 ASIA-PACIFIC
  8.2.1 CHINA
  8.2.2 INDIA
8.3 EUROPE
  8.3.1 WESTERN EUROPE
  8.3.2 EASTERN EUROPE
  8.3.3 SOUTHERN EUROPE
8.4 NORTH AMERICA
  8.4.1 U.S.
  8.4.2 CANADA
  8.4.3 MEXICO
8.5 REST OF THE WORLD
  8.5.1 SOUTH AMERICA
    8.5.1.1 BRAZIL
    8.5.1.2 VENEZUELA
  8.5.2 MIDDLE EAST
    8.5.2.1 SAUDI ARABIA
    8.5.2.2 UAE
    8.5.2.3 QATAR
  8.5.3 AFRICA
    8.5.3.1 NIGERIA
    8.5.3.2 ANGOLA
    8.5.3.3 ALGERIA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW
  9.1.1 NEW PRODUCT LAUNCHES & NEW TECHNOLOGIES: THE MOST POPULAR GROWTH STRATEGIES
9.2 MAXIMUM DEVELOPMENTS IN 2013
9.3 EXPANSIONS, INVESTMENTS, & RESTRUCTURES
9.4 NEW PRODUCT LAUNCHES & NEW TECHNOLOGIES
9.5 MERGERS & ACQUISITIONS
9.6 AGREEMENTS, COLLABORATIONS, JOINT VENTURES, & PARTNERSHIPS

10 COMPANY PROFILES

(Overview, Financials, Products & Services, Strategy, and Developments)*

10.1 INTRODUCTION
10.2 THE DOW CHEMICAL COMPANY
10.3 BASF S.E.
10.4 AKZO NOBEL OILFIELD (AKZO NOBEL N.V.)
10.5 KEMIRA OYJ
10.6 SOLVAY
10.7 HALLIBURTON COMPANY
10.8 SCHLUMBERGER LIMITED
10.9 BAKER HUGHES INCORPORATED
10.10 CLARIANT AG
10.11 E.I. DUPONT DE NEMOURS AND COMPANY
10.12 EVONIK INDUSTRIES AG
10.13 GE POWER & WATER PROCESS TECHNOLOGIES (GENERAL ELECTRIC)
10.14 ASHLAND INC.
10.15 INNOSPEC INC.

*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company

11 APPENDIX

11.1 INDUSTRY EXPERTS
11.2 RECENT DEVELOPMENTS
11.3 DISCUSSION GUIDE
11.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
11.5 AVAILABLE CUSTOMIZATIONS
11.6 RELATED REPORTS

LIST OF TABLES

TABLE 1 SCALE INHIBITORS MARKET SIZE: BY TYPE, 2013-2020 (USD MILLION)
TABLE 2 SCALE INHIBITORS MARKET SIZE: BY TYPE, 2013-2020 (KT)
TABLE 3 SCALE INHIBITORS MARKET SIZE IN PHOSPHONATES, BY REGION, 2013-2020 (USD MILLION)
TABLE 4 SCALE INHIBITORS MARKET SIZE IN PHOSPHONATES, BY REGION, 2013-2020 (KT)
TABLE 5 SCALE INHIBITORS MARKET SIZE IN CARBOXYLATE/ACRYLIC, BY REGION, 2013-2020 (USD MILLION)
TABLE 6 SCALE INHIBITORS MARKET SIZE IN CARBOXYLATE/ACRYLIC, BY REGION, 2013-2020 (KT)
TABLE 7 SCALE INHIBITORS MARKET SIZE IN SULFONATES, BY REGION, 2013-2020 (USD MILLION)
TABLE 8 SCALE INHIBITORS MARKET SIZE IN SULFONATES, BY REGION, 2013-2020 (KT)
TABLE 9 SCALE INHIBITORS MARKET SIZE IN OTHERS, BY REGION, 2013-2020 (USD MILLION)
TABLE 10 SCALE INHIBITORS MARKET SIZE IN OTHERS, BY REGION, 2013-2020 (KT)
TABLE 11 SCALE INHIBITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
TABLE 12 SCALE INHIBITORS MARKET SIZE, BY REGION, 2013-2020 (KT)
TABLE 13 SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 14 SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 15 ASIA-PACIFIC: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 16 ASIA-PACIFIC: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (KT)
TABLE 17 ASIA-PACIFIC: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 18 ASIA-PACIFIC: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 19 CHINA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 20 CHINA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 21 INDIA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 22 INDIA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 23 EUROPE: SCALE INHIBITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
TABLE 24 EUROPE: SCALE INHIBITORS MARKET SIZE, BY REGION, 2013-2020 (KT)
TABLE 25 EUROPE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 26 EUROPE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 27 WESTERN EUROPE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 28 WESTERN EUROPE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 29 EASTERN EUROPE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 30 EASTERN EUROPE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 31 SOUTHERN EUROPE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 32 SOUTHERN EUROPE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 33 NORTH AMERICA: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 34 NORTH AMERICA: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (KT)
TABLE 35 NORTH AMERICA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 36 NORTH AMERICA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 37 U.S.: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 38 U.S.: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 39 CANADA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 40 CANADA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 41 MEXICO: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 42 MEXICO: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 43 ROW: SCALE INHIBITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
TABLE 44 ROW: SCALE INHIBITORS MARKET SIZE, BY REGION, 2013-2020 (KT)
TABLE 45 ROW: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 46 ROW: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 47 SOUTH AMERICA: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 48 SOUTH AMERICA: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (KT)
TABLE 49 SOUTH AMERICA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 50 SOUTH AMERICA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 51 BRAZIL: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 52 BRAZIL: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 53 VENEZUELA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 54 VENEZUELA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 55 MIDDLE EAST: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 56 MIDDLE EAST: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (KT)
TABLE 57 MIDDLE EAST: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 58 MIDDLE EAST: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 59 SAUDI ARABIA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 60 SAUDI ARABIA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 61 UAE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 62 UAE: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 63 QATAR: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 64 QATAR: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 65 AFRICA: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 66 AFRICA: SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2013-2020 (KT)
TABLE 67 AFRICA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 68 AFRICA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 69 NIGERIA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 70 NIGERIA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 71 ANGOLA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 72 ANGOLA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 73 ALGERIA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
TABLE 74 ALGERIA: SCALE INHIBITORS MARKET SIZE, BY TYPE, 2013-2020 (KT)
TABLE 75 EXPANSIONS & INVESTMENTS, 2012-2015
TABLE 76 NEW PRODUCT LAUNCHES & NEW TECHNOLOGIES, 2012-2015
TABLE 77 MERGERS & ACQUISITION, 2012-2015
TABLE 78 AGREEMENTS, COLLABORATIONS, JOINT VENTURES, & PARTNERSHIPS, 2012-2015
TABLE 79 THE DOW CHEMICAL COMPANY: PRODUCTS AND SERVICES
TABLE 80 BASF S.E.: PRODUCTS AND SERVICES
TABLE 81 AKZO NOBEL N.V.: PRODUCTS AND SERVICES
TABLE 82 KEMIRA OYJ: PRODUCTS AND SERVICES
TABLE 83 SOLVAY: PRODUCTS AND SERVICES
TABLE 84 HALLIBURTON COMPANY: PRODUCTS AND SERVICES
TABLE 85 SCHLUMBERGER LIMITED: PRODUCTS AND SERVICES
TABLE 86 BAKER HUGHES INCORPORATED: PRODUCTS AND SERVICES
TABLE 87 CLARIANT AG: PRODUCTS AND SERVICES
TABLE 88 E. I. DUPONT DE NEMOURS AND COMPANY: PRODUCTS AND SERVICES
TABLE 89 EVONIK INDUSTRIES AG: PRODUCTS AND SERVICES
TABLE 90 GE POWER & WATER PROCESS TECHNOLOGIES: PRODUCTS AND SERVICES
TABLE 91 ASHLAND INC.: PRODUCTS AND SERVICES
TABLE 92 INNOSPEC INC.: PRODUCTS AND SERVICES

Sulfonate-based scale inhibitor segment is growing significantly, faster than phosphonate-based scale inhibitor segment, estimated at $XX million in 2013 and is projected to register a CAGR of XX% between 2014 and 2019 to reach $XX million by 2019. This fast growth is largely driven by increase in the oilfield operations that use conventional scale inhibitor, such as PVS (Polyvinyl sulfonate) and vinyl sulphonic acid.

Overall the scale inhibitor market was estimated at $XX million in 2013 and is registering a healthy CAGR of XX% during the forecast period 2014–2019 to reach $XX million by 2019.

The sulfonate-based scale inhibitor segment was estimated at $XX million in 2013 and projected to register a CAGR of XX% during the forecast period 2014–2019 to reach $XX million by 2019.

The different kinds of scale inhibitor in this category include vinyl sulphonic acid or vinyl sulfonate salts, styrene-p-sulphonic acid or styrene sulfonate salts, acrylamido-2-methylpropanesulfonic acid (AMPS), PVS (polymeric vinyl sulfonate), and many other sulfonate-based scale inhibitor.

The sulfonate-based scale inhibitor are used in the oil industry in the form of copolymers. The PVS is deployed in the down hole to control barium sulphate scales and is considered a more effective scale inhibitor than most others under the prevailing down hole conditions.

The power & construction segment led the scale inhibitor application market in 2013 which was estimated to be valued at $XX million and is expected to grow at a CAGR of XX% from 2014 to 2019 to reach $XX by 2019.

Water and wastewater treatment segment is the fastest growing segment for scale inhibitor application which is expected to grow at a CAGR of XX% during the forecast period owing to a greater demand coming fromAsia-Pacific and RoW.

The desalination market of Oman is expected to reach $XX million by 2016, Saudi Arabia is the world’s largest market for desalination plants. Moreover, the government initiatives are scheduled to undertake 10 new plants by 2016 with over $XX billion of investment in desalination. Various steps have made RoW the second largest market for scale inhibitor in water and wastewater treatment application segment.

RoW was estimated to be $XX million in 2013 and is expected to reach $XX million by 2019 at a CAGR of XX%.

The increase in the demand for water treatment is set to increase by XX% by 2016, making APAC the fastest growing region in the scale inhibitor market with a CAGR of XX% to reach $XX million by 2019.

APAC is expected to witness an increase in demand for water by XX% in 2013 and a decent growth in the membrane filtration in the CAGR range of seven to eight% during the forecast period has led to an increase in the demand for scale inhibitor in RoW and APAC.



More Publications